003020 立方制药
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资185,4954.60%177,332174,675163,95114,398
投资性房地产27,756-1.43%28,15824,83225,6172,671
固定资产919,463-0.92%928,036692,904427,255182,376
在建工程53,4603.48%51,664269,340459,661340,893
无形资产95,400-2.27%97,615105,240113,28583,382
商誉74,4410.00%74,44174,44174,4410
其他非流动资产57,67910.19%52,34359,04968,32345,129
1,413,6930.29%1,409,5871,400,4801,332,533668,850

流动资产
货币资金285,062-31.13%413,894439,694502,929642,580
应收账款434,759-3.91%452,439369,023258,447320,921
存货227,63211.31%204,499220,484242,914361,765
其他流动资产289,180174.35%105,407156,294146,856127,281
1,236,6335.13%1,176,2391,185,4951,151,1471,452,547

流动负债
短期借款0--0000
应付票据0--000213,720
应付帐款366,4044.85%349,461347,525301,251246,935
其他流动负债175,7852.73%171,120234,427241,479161,973
542,1884.15%520,581581,952542,729622,628
流动资产净值694,4455.92%655,658603,543608,417829,919
资产总额减流动负债2,108,1372.08%2,065,2452,004,0231,940,9501,498,769

非流动负债
长期借款69,65216.78%59,64559,65231,0140
应付债券0--0000
其他非流动负债51,428-4.71%53,96831,77336,43818,907
121,0816.57%113,61391,42467,45218,907

总权益
    实收股本190,1820.00%190,182191,572159,675122,467
    储备项目1,654,2192.19%1,618,7621,546,3151,525,8511,357,395
股东权益1,844,4011.96%1,808,9441,737,8871,685,5261,479,862
非控股权益142,655-0.02%142,688174,712187,9720